If you have questions, please call us for more information about clinical trials or use our online form.
- Cancer clinical trials: 414-805-8900
- Noncancer clinical trials: 414-955-8555
Learn more about clinical trials basics and early-phase clinical trials, as well as some of the unique features our research program, including our Translational Research Unit. Froedtert & MCW health network is also part of the National Institutes of Health All of Us Research Program.
Displaying 231 - 240 of 274
Exogenous Tuning of Neural Oscillations as a Mode of Treatment in Post-stroke Subacute Aphasia
Objective
Transcranial Alternating Current Stimulation (tACS) in Subacute Aphasia
Protocol No
NEURO-MCW-TACS-SUBACUTEAPHASIA
Categories
A Phase 1 Study of NM32-2668 (Anti-ROR1/Anti-CD3/Anti-HSA Tri-Specific Antibody) in Adult Patients with Selected Advanced Solid Tumors
Objective
A Phase 1 Study of NM32-2668 in Patients with Selected Advanced Solid Tumors
Protocol No
NUMAB-NB-NM032-2668-101
Phase 1 Study of Venetoclax/Azacitidine or Venetoclax in Combination with Ziftomenib (KO-539) or Standard Induction Cytarabine/Daunorubicin (7+3) Chemotherapy in Combination with Ziftomenib for the Treatment of Patients with Acute Myeloid Leukemia
Objective
Study of ziftomenib in combination with venetoclax or chemotherapy for treatment of AML patients
Protocol No
KURA-KO-MEN-007
Categories
Randomized Phase II/III Trial of First Line Platinum/Etoposide with or without Atezolizumab (NSC#783608) in Patients with Advanced or Metastatic Poorly Differentiated Extrapulmonary Neuroendocrine Carcinomas (NEC)
Objective
Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung
Protocol No
SWOG-S2012
Randomized Phase II Stereotactic Ablative Radiation Therapy (SABR) for Metastatic Unresected Renal Cell Carcinoma (RCC) Receiving Immunotherapy (SAMURAI)
Objective
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Study (SAMURAI)
Protocol No
NRG-GU012-SAMURAI
Categories
A Randomized Phase 3 Trial of Continuous vs. Intermittent Maintenance Therapy with Zanubrutinib as Upfront Treatment in Older Patients with Mantle Cell Lymphoma
Objective
Trial of Zanubrutinib in older patients with mantle cell lymphoma
Protocol No
ALLIANCE-A052101
Categories
Every Day Counts: A Lifestyle Program for Women with Metastatic Breast Cancer
Objective
Every Day Counts: A Lifestyle Program for Women with Metastatic Breast Cancer
Protocol No
IIT-STOLLEY-EVERY-DAY-COUNTS-2
Categories
A Randomized Phase II Trial of Consolidation Therapy Following CD19 CAR T-Cell Treatment for Relapsed/Refractory Diffuse Large B-Cell Lymphoma or Grade IIIB Follicular Lymphoma
Objective
To find out if this approach is better or worse than the usual approach for DLBCL patients receiving CAR T-cell therapy. The usual approach for Relapsed/Refractory DLBCL patients is follow-up visits with no further therapy.
Protocol No
SWOG-S2114
Categories
Preventing Common Obstetric Complications Through an Immersive, Medically Tailored Meal Program (PLATE)
Objective
Preventing Common Obstetric Complications Through an Immersive, Medically Tailored Meal Program
Protocol No
OBG-IIT-PALATNIK-AHW-PLATE
Categories
LUNGMAP: A Master Protocol to Evaluate Biomarker-Driven Therapies and Immunotherapies in Previously-Treated Non-Small Cell Lung Cancer (Lung-MAP Screening Study)
Objective
Targeted Treatment for Advanced Non-Small Cell Lung Cancer
Protocol No
SWOG-LUNGMAP
Categories